Acutus Medical, Inc.

AFIB Healthcare Medical Devices

In the quarter to December 2024, revenue grew 204.2%, EPS grew 95.9% and free cash flow grew 76.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

0.00 0.00 NaN
Market cap
$1.7M
P/E
0.0×
Fwd P/E
−0.5×
Dividend yield
—
F-score
3/9
Altman Z
−28.52
Beneish M
−2.49
Dividend safety
n/a
Older periods Mar '24 Jun '24 Sep '24 Dec '24
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
0.56 0.07 0.16 0.09
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(0.32) (0.13) (0.64) (0.44)
P/B ratio
0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
2.10 1.62 1.44 1.01
EV/EBITDA
0.00 0.00 0.00 10.86
EV/Operating CF
(0.31) (0.35) (0.49) (0.64)
EV/FCF
(0.31) (0.36) (0.49) (0.64)
Quick Ratio
2.81 1.82 1.54 1.76
Current Ratio
3.48 2.30 1.85 2.06
Net Debt/EBITDA
(59.39) 24.91 21.62 41.31
Debt/Assets
83.09% 90.73% 100.58% 113.69%
Debt/Equity
(8.61) (6.70) (3.14) (2.81)
Asset Turnover
0.12 0.18 0.26 0.49
Operating CF/Net income
10.45 7.63 0.66 2.89
Capex/Depreciation
(0.32) (0.08) (0.01) 0.05
Interest Coverage
(0.39) 0.20 0.35 (0.20)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
92.06% 53.91% 44.02% 35.80%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
5.57% 3.13% 2.43% 0.00%
Graham Net Nets
(2.11) (13.26) (6.42) (8.21)
Graham Number
2.64 2.48 3.34 1.69
Earnings Yield
(1,275.28%) (5,651.67%) (1,794.37%) (545.33%)
Free Cash Flow Yield
(1,208.96%) (6,225.47%) (1,879.05%) (1,778.87%)
Revenue per Share
0.12 0.14 0.18 0.24
Operating CF per Share
(0.57) (0.23) (0.12) (0.14)
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.57) (0.24) (0.12) (0.14)
Cash per Share
0.67 0.45 0.42 0.47
Shareholders Equity per Share
(0.14) (0.16) (0.35) (0.39)
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
(0.14) (0.16) (0.35) (0.39)
Free Cash Flow
(17.03) (7.01) (3.70) (4.02)
Working Capital
24.53 16.08 12.49 13.14
Capital Expenditures
(0.10) (0.04) 0.00 0.04
Net Current Asset Value
(11.28) (11.82) (15.31) (14.66)
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.03 0.01 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
6.55 8.45 9.46 9.62
Average Payables
4.37 3.59 3.23 2.02
Average Inventory
10.41 10.44 9.96 3.03
Average Assets
78.83 67.88 58.45 41.30
Average Common Equity
28.22 19.47 10.70 (6.24)

Fold the line items

Columns are period end dates